UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 前立腺生検の解釈 interpretation of prostate biopsy
English Journal
- Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
- Yun S1, Han YS2,3, Lee JH4, Kim S1, Lee SH5,3.
- Anticancer research.Anticancer Res.2017 Jun;37(6):2975-2984.
- PMID 28551635
- Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.
- Day FR1, Thompson DJ2, Helgason H3,4, Chasman DI5,6, Finucane H7,8, Sulem P3, Ruth KS9, Whalen S10, Sarkar AK11,12, Albrecht E13, Altmaier E14,15, Amini M16, Barbieri CM17, Boutin T18, Campbell A19, Demerath E20, Giri A21,22, He C23,24, Hottenga JJ25, Karlsson R26, Kolcic I27, Loh PR7,28, Lunetta KL29,30, Mangino M31,32, Marco B33, McMahon G34, Medland SE35, Nolte IM16, Noordam R36, Nutile T37, Paternoster L34,38, Perjakova N39, Porcu E40, Rose LM5, Schraut KE41,42, Segrè AV43, Smith AV44,45, Stolk L46, Teumer A47, Andrulis IL48,49, Bandinelli S50, Beckmann MW51, Benitez J52,53, Bergmann S54,55, Bochud M56, Boerwinkle E57, Bojesen SE58,59,60, Bolla MK2, Brand JS26, Brauch H61,62,63, Brenner H63,64,65, Broer L46, Brüning T66, Buring JE5,6, Campbell H42, Catamo E67, Chanock S68, Chenevix-Trench G69, Corre T54,55,56, Couch FJ70, Cousminer DL71,72, Cox A73, Crisponi L40, Czene K26, Davey Smith G34,38, de Geus EJCN25, de Mutsert R74, De Vivo I7,75, Dennis J2, Devilee P76,77, Dos-Santos-Silva I78, Dunning AM79, Eriksson JG80, Fasching PA51,81, Fernández-Rhodes L82, Ferrucci L83, Flesch-Janys D84,85, Franke L86, Gabrielson M26, Gandin I33, Giles GG87,88, Grallert H14,15,89, Gudbjartsson DF3,4, Guénel P90, Hall P26, Hallberg E91, Hamann U92, Harris TB93, Hartman CA94, Heiss G82, Hooning MJ95, Hopper JL88, Hu F75,96, Hunter DJ7,75,96, Ikram MA97, Im HK98, Järvelin MR99,100,101,102,103, Joshi PK42, Karasik D6,104, Kellis M11,12, Kutalik Z54,56, LaChance G31, Lambrechts D105,106, Langenberg C1, Launer LJ93, Laven JSE107, Lenarduzzi S67, Li J26, Lind PA35, Lindstrom S108, Liu Y109, Luan J1, Mägi R39, Mannermaa A110,111,112, Mbarek H25, McCarthy MI113,114,115, Meisinger C14,116, Meitinger T117, Menni C31, Metspalu A39, Michailidou K2,118, Milani L39, Milne RL87,88, Montgomery GW119, Mulligan AM120,121, Nalls MA122, Navarro P18, Nevanlinna H123, Nyholt DR124, Oldehinkel AJ125, O'Mara TA69, Padmanabhan S126, Palotie A28,127,128,129,130,131, Pedersen N26, Peters A14,89, Peto J78, Pharoah PDP2,79, Pouta A132, Radice P133, Rahman I134, Ring SM34,38, Robino A67, Rosendaal FR74, Rudan I42, Rueedi R54,55, Ruggiero D37, Sala CF17, Schmidt MK135,136, Scott RA1, Shah M79, Sorice R37, Southey MC137, Sovio U99,138, Stampfer M7,75, Steri M40, Strauch K13,139, Tanaka T83, Tikkanen E131,140, Timpson NJ34,38, Traglia M17, Truong T90, Tyrer JP79, Uitterlinden AG46,97, Edwards DRV22,141,142, Vitart V18, Völker U143, Vollenweider P144, Wang Q2, Widen E131, van Dijk KW77,145,146, Willemsen G25, Winqvist R147,148, Wolffenbuttel BHR149, Zhao JH1, Zoledziewska M40, Zygmunt M150, Alizadeh BZ16, Boomsma DI25, Ciullo M37, Cucca F40,151, Esko T28,39, Franceschini N82, Gieger C14,15,89, Gudnason V44,45, Hayward C18, Kraft P7,152, Lawlor DA34,38, Magnusson PKE26, Martin NG35, Mook-Kanamori DO74,153, Nohr EA154, Polasek O27, Porteous D19, Price AL7,8,28, Ridker PM5,6, Snieder H16, Spector TD31, Stöckl D14,155, Toniolo D17, Ulivi S67, Visser JA46, Völzke H47, Wareham NJ1, Wilson JF18,42; LifeLines Cohort Study; InterAct Consortium; kConFab/AOCS Investigators; Endometrial Cancer Association Consortium; Ovarian Cancer Association Consortium; PRACTICAL consortium, Spurdle AB69, Thorsteindottir U3,44, Pollard KS10,156, Easton DF2,79, Tung JY157, Chang-Claude J158,159, Hinds D157, Murray A9, Murabito JM30,160, Stefansson K3,44, Ong KK1,161, Perry JRB1.
- Nature genetics.Nat Genet.2017 Jun;49(6):834-841. doi: 10.1038/ng.3841. Epub 2017 Apr 24.
- PMID 28436984
- Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placebo.
- Flamiatos JF1, Beer TM2, Graff JN2,3, Eilers KM2, Tian W4, Sekhon HS5, Garzotto M6,7.
- BJU international.BJU Int.2017 May;119(5):709-716. doi: 10.1111/bju.13612. Epub 2016 Aug 23.
- PMID 27480340
Japanese Journal
- 高田 聡,吉川 元清,細川 幸成 [他],林 美樹,藤本 清秀,平尾 佳彦
- 泌尿器科紀要 56(3), 173-175, 2010-03
- … Pathological examination demonstrated small cell carcinoma in the bladder tumor specimen and well differentiated adenocarcinoma (cT1c) with a Gleason score of 3+4 in the prostatic specimen. … He did not receive adjuvant chemotherapybecause of the poor postoperative systemic condition and he died of acute myocardial infarction 5 months later. …
- NAID 120002036633
- The Effect of Doxazosin Mesilate on Cerebral Blood Flow in Patients with Hypertension and Chronic Cerebral Infarction
- Usuda Kazuhiro,Katayama Yasuo
- 日本医科大学雑誌 76(3), 148-153, 2009
- … α<sub>1</sub>-Adrenoceptor antagonists are useful antihypertensive agents for patients with hypertension who have hyperlipidemia, benign prostatic hyperplasia, or pheochromocytoma. … The purpose of this study was to evaluate the effect of the α<sub>1</sub>-adrenoceptor antagonist, doxazosin mesilate, on cerebral blood flow (CBF) and flow velocity in the common carotid artery in patients with hypertension and chronic cerebral infarction.<br> …
- NAID 130004146985
- Improvement of bladder storage function by α1-blocker depends on the suppression of C-fiber afferent activity in rats
- YOKOYAMA Osamu,YUSUP Anwar,OYAMA Nobuyuki,AOKI Yoshitaka,TANASE Kazuya,MATSUTA Yosuke,MIWA Yoshiji,AKINO Hironobu
- Neurourology and urodynamics 25(5), 461-467, 2006
- … Aims α1-blockers improve voiding symptoms through the reduction of prostatic and urethral smooth muscle tone; … Using a rat model of detrusor overactivity caused by cerebral infarction (CI), we undertook the present study to determine whether the effect of an 1-blocker, naftopidil, is dependent on the suppression of C-fiber afferents. …
- NAID 120000997270
Related Links
- 7 Aug 2000 ... Background. The prostate gland is subject to the same pathologic processes that occur in other organs such as the heart. An infarct of the prostate is rare and is usually reported in transurethral resections of the prostate gland ...
- International Urology and Nephrology 7 (4), pp. 315--319 (1975). Prostatic Infarction. J. MEaYERX, J. VAI~GA. Departments of Pathology and Urology, Szabolcs-Szatm~ir County Council Hospital,. Hungary. (Received December 2, 1974) ...
★リンクテーブル★
[★]
- 関
- prostate、prostate gland